Q32 Bio (QTTB) Operating Leases (2020 - 2025)
Historic Operating Leases for Q32 Bio (QTTB) over the last 6 years, with Q3 2025 value amounting to $5.1 million.
- Q32 Bio's Operating Leases fell 1160.02% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 1160.02%. This contributed to the annual value of $5.6 million for FY2024, which is 979.51% down from last year.
- Q32 Bio's Operating Leases amounted to $5.1 million in Q3 2025, which was down 1160.02% from $5.3 million recorded in Q2 2025.
- In the past 5 years, Q32 Bio's Operating Leases ranged from a high of $28.3 million in Q3 2022 and a low of $5.1 million during Q3 2025
- Moreover, its 5-year median value for Operating Leases was $12.0 million (2021), whereas its average is $15.3 million.
- Per our database at Business Quant, Q32 Bio's Operating Leases skyrocketed by 14467.28% in 2022 and then crashed by 7818.9% in 2024.
- Q32 Bio's Operating Leases (Quarter) stood at $23.7 million in 2021, then increased by 17.85% to $27.9 million in 2022, then plummeted by 77.62% to $6.2 million in 2023, then dropped by 9.8% to $5.6 million in 2024, then decreased by 9.14% to $5.1 million in 2025.
- Its last three reported values are $5.1 million in Q3 2025, $5.3 million for Q2 2025, and $5.5 million during Q1 2025.